2016-11-15T07:47:05-08:00 2015-12-31 Bencivenga Ward & Company CPAs PC 420 Columbus Avenue Suite 304 Valhalla NY 105951382 990 2015-01-01 201082179 ALZHEIMERs DRUG DISCOVERY FOUNDATION ALZH 2129018000 57 WEST 57TH ST NEW YORK NY 10019 HOWARD FILLIT MD FOUNDING EXEC DIR 2016-11-15 true William A Ward CPA P01200939 9147695005 2015 2017-02-10 21:41:12Z HOWARD FILLIT MD 57 WEST 57TH ST NEW YORK NY 10019 30351836 false false X www.AlzDiscovery.org X 2004 DE ACCELERATE THE DISCOVERY AND DEVELOPMENT OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE, RELATED DEMENTIAS AND COGNITIVE AGING 20 19 0 0 10332886 18913013 2026078 1255136 1575 4668 -391977 2172934 11968562 22345751 8516141 12471388 0 180888 148181 0 21733 1315289 521283 10012318 13140852 1956244 9204899 19304546 31129927 10841908 13608228 8462638 17521699 ACCELERATE THE DISCOVERY AND DEVELOPMENT OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE, RELATED DEMENTIAS AND COGNITIVE AGING false false 13050605 12471388 1255136 EXEMPT PURPOSE ACHIEVEMENT IS TO ACCELERATE THE DISCOVERY AND DEVELOPMENT OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE, RELATED DEMENTIAS AND COGNITIVE AGING THROUGH THE GRANTING OF FUNDS TO ORGANIZATIONS AND THE SPONSORSHIP OF CONFERENCES THAT BRING TOGETHER ACADEMIC AND BIO TECHNOLOGY SCIENTISTS CONDUCTING DRUG DISCOVERY RESEARCH IN THE FIELD OF ALZHEIMER'S DISEASE, RELATED DEMENTIAS AND COGNITIVE AGING. 13050605 true true false false false false false false false false false false false false false true false true false false true true false false true false false true false true false false false false false false false false false false false true false false false false true false false false false true 14 0 false 0 false false false false false false false true true false 0 false false false false false false false false false false X 20 19 true false true false true true true true true false false true true true true true true false false false GA IL NY X MR ETHAN HUTCHINSON 2129018000 57 West 57th St New York NY 10595 X LEONARD A LAUDER Co-Chair / Gov 1.00 0.00 X X 0 0 0 RONALD S LAUDER Co-Chair / Gov 1.00 0.00 X X 0 0 0 HOWARD FILLIT MD EXEC DIR/GOV 0.00 40.00 X X 0 466752 272030 LAURENCE C LEEDS Jr GOVERNOR 1.00 0.00 X 0 0 0 ROBERT J APPEL GOVERNOR 0.00 0.00 X 0 0 0 NANCY CORZINE President/Gov 1.00 0.00 X X 0 0 0 ROBERTA DIAZ BRINTON PHD GOVERNOR 0.00 0.00 X 0 0 0 ROBERT A BELFER Governor 1.00 0.00 X 0 0 0 RANDAL SANDLER Governor 1.00 0.00 X 0 0 0 SALLY SUSMAN Governor 1.00 0.00 X 0 0 0 BONNIE PFEIFER EVANS Governor 1.00 0.00 X 0 0 0 LADY LYNN DE ROTHSCHILD Governor 1.00 0.00 X 0 0 0 ALICE SHURE Governor 1.00 0.00 X 0 0 0 MELVIN R GOODES Governor 1.00 0.00 X 0 0 0 PETER SOLOMON GOVERNOR 1.00 0.00 X 0 0 0 PAULA ZAHN GOVERNOR 1.00 0.00 X 0 0 0 NANCY GOODES GOVERNOR 1.00 0.00 X 0 0 0 THOMAS F MCWILLIAMS GOVERNOR 1.00 0.00 X 0 0 0 LANNY EDELSOHN MD GOVERNOR 0.00 0.00 X 0 0 0 GARY M LAUDER GOVERNOR 0.00 0.00 X 0 0 0 BRUCE MCEWEN PHD GOVERNOR 0.00 0.00 X 0 0 0 RICHARD MOHS PHD GOVERNOR 0.00 0.00 X 0 0 0 STEVEN MARC PAUL MD GOVERNOR 0.00 0.00 X 0 0 0 LISA SOMAR ASST TREAS/SEC 1.00 0.00 X 0 0 0 KEVIN DIETERICH Treasurer 1.00 0.00 X 0 0 0 466752 272030 0 false true false 0 1417359 17495654 7901915 18913013 CONFERENCE REG FEES 335118 335118 PRI'S & GRANT RETURNS 920018 920018 1255136 23716 23716 0 0 0 7471262 7490310 -19048 -19048 -19048 2688709 1417359 515775 2172934 2172934 0 0 0 22345751 1236088 2196650 10639317 10639317 0 1832071 1832071 0 0 0 109764 109764 0 0 38417 38417 0 0 0 0 0 0 30184 14115 16069 0 141431 86668 50378 4385 19619 7691 11928 0 0 0 0 300840 295840 1494 3506 0 0 0 0 COMMUNICATION 29209 26722 573 1914 0 13140852 13050605 68514 21733 15640 171303 4285311 4702394 4055417 4962392 0 0 0 0 0 25000 25366 0 10809963 20649664 0 536800 0 113215 82008 19304546 31129927 35277 100536 10745281 13504012 61350 3680 10841908 13608228 X 8188170 12974967 274468 4546732 8462638 17521699 19304546 31129927 X 9204899 -145838 X false true X false false X 7946390 9676164 9342340 10332886 21085948 58383728 0 0 7946390 9676164 9342340 10332886 21085948 58383728 7806422 50577306 6320 6352 4007 9836 1115 27630 0 240733 354442 274603 2026078 1255136 4150992 62562350 0.80840 0.70620 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X Part X : FIN48 Footnote THE FOUNDATION IS SUBJECT TO THE PROVISIONS OF THE FINANCIAL STANDARDS BOARD'S ACCOUNTING STANDARDS CODIFICATION ("ASC") TOPIC 740-10-05 RELATING TO ACCOUNTING AND REPORTING FOR UNCERTAINTY IN INCOME TAXES. THIS REQUIRED MANAGEMENT TO EVALUATE TAX POSITIONS TAKEN AND RECOGNIZE A TAX LIABILITY (OR ASSET) IF THE FOUNDATION HAS TAKEN AN UNCERTAIN POSITION THAT MORE LIKELY THAN NOT WOULD NOT BE SUSTAINED UPON EXAMINATION BY THE INTERNAL REVENUE SERVICE ("IRS"). DUE TO THE FOUNDATION'S GENERAL NOT-FOR-PROFIT STATUS, MANAGEMENT BELIEVES THERE ARE NO TAX POSITIONS THAT WOULD HAVE A MATERIAL IMPACT ON THE FOUNDATION'S FINANCIAL STATEMENTS. THE FOUNDATION IS SUBJECT TO ROUTINE AUDITS BY TAXING JURISDICTIONS; HOWEVER, THERE ARE CURRENTLY NO AUDITS FOR ANY TAX PERIODS IN PROGRESS. DUE TO THE EXPIRATION OF THE STATUTE OF LIMITATIONS, THE FOUNDATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS FOR THE YEARS PRIOR TO 2012.PART XI LINE 2B AND XII LINE 2ADURING THE FOUNDATION'S 2015 TAX YEAR, THE INSTITUTE FOR THE STUDY OF AGING, A RELATED 501(C) (3) TAX-EXEMPT PRIVATE FOUNDATION, PROVIDED THE FOUNDATION WITHOUT CHARGE AS AN IN-KIND CONTRIBUTION SERVICES HAVING A VALUE OF $3,500,273. THESE SERVICES INCLUDED SHARED PERSONNEL AND OFFICE SPACE AND ARE FURTHER DETAILED IN PART V OF SCHEDULE R. true EUROPE 0 0 GRANTS TO RECIPIENTS ALZHEIMER'S DISEASE RESEARCH 1436635 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS ALZHEIMER'S DISEASE RESEARCH 145157 NORTH AMERICA 0 0 GRANTS TO RECIPIENTS ALZHEIMER'S DISEASE RESEARCH 164990 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS TO RECIPIENTS ALZHEIMER'S DISEASE RESEARCH 82789 1829571 1829571 EAST ASIA & PAC RESEACH AD 145157 ELECTRONIC EUROPE RESEARCH AD 135000 ELECTRONIC EUROPE RESEARCH AD 250000 ELECTRONIC EUROPE RESEARCH AD 456905 ELECTRONIC EUROPE RESEARCH AD 533330 ELECTRONIC EUROPE RESEARCH AD 61400 ELECTRONIC MIDDLE ET & NAF RESEARCH AD 82789 ELECTRONIC NORTH AMERICA RESEARCH AD 164990 ELECTRONIC 7 1 false false false false false false Part I, Line 2 - Grantmakers Explanation For Monitoring Use of Funds Outside US GRANT RECIPIENTS ARE SELECTED THROUGH A RIGOROUS PEER-REVIEW PROCESS AS WELL AS AN INTERNAL REVIEW AND BOARD APPROVAL PROCESS. GRANTS TO BOTH U.S. AND INTERNATIONAL INSTITUTIONS ARE CLOSELY MONITORED. GRANTEES MUST SUBMIT MIDYEAR AND END-OF-GRANT PROGRESS AND FINANCIAL REPORTS. SUBSEQUENT PAYMENTS TO GRANT RECIPIENTS ARE CONTINGENT UPON THE RECEIPT AND SATISFACTORY REVIEW OF THESE REPORTS. PROGRESS OF GRANT RECIPIENTS IS COMMUNICATED TO THE BOARD OF GOVENORS PERIODICALLY. false NY IL GA DINNER GALA 2775308 842847 1932461 107193 105773 SCIENCE PROGRAM 1082405 515087 567318 99221 79556 1 248355 59425 188930 96894 27138 4106068 1417359 2688709 303308 212467 515775 2172934 true BOSTON U SCHOOL OF MEDICINE 72 E CONCORD ST BOSTON MA 02118 042103547 236516 0 ALZHEIMERS RESEARCH CENTER FOR BIOMOLECULAR THERA UNIV OF MD 685 WEST BALTIMORE BALTIMORE MD 21201 150000 0 ALZHEIMERS RESEARCH COLUMBIA UNIVERSITY MEDICAL C 2700 BROADWAY NEW YORK NY 10025 135598093 508158 0 ALZHEIMERS RESEARCH EMORY UNIVERSITY 1784 DECATUR RD SUITE 510 ATLANTA GA 30322 560566256 973777 0 ALZHEIMERS RESEARCH GEORGETOWN UNIVERSITY 3970 RESERVOIR RD WASHINGTON DC 20007 530196603 2059207 0 ALZHEIMERS RESEARCH INTRAMURAL RESEACH NIH 251 BAYVIEW BLVD BALTIMORE MD 21224 80264 0 ALZHEIMERS RESEARCH MASS GENERAL HOSPITALHARVARD BLDG 149/13TH ST 6TH FLOOR CHARLESTOWN MA 02129 042697983 731805 0 ALZHEIMERS RESEARCH MAYO CLINIC 200 1ST ST WEST ROCHESTER MN 55905 416011702 300000 0 ALZHEIMERS RESEARCH MOUNT SINAI HOSPITAL 1468 MADISON AVE NEW YORK NY 10029 158171 0 ALZHEIMERS RESEARCH NORTHEASTERN UNIVERSTIY 360 HUNTINGTON AVE BOSTON MA 02115 175000 0 ALZHEIMERS RESEARCH OHIO STATE CTR FOR MOLECULAR 1060 CARMACK ROAD COLUMBUS OH 43210 316401599 47397 0 ALZHEIMERS RESEARCH OHIO STATE UNIVERSITY 281 W LANE AVE COLUMBUS OH 43210 316025986 244008 0 ALZHEIMERS RESEARCH PHARMATROPHIX 2500 WACHOVIA CAPITAL CENTER RALEIGH NC 27602 141973571 500000 0 ALZHEIMERS RESEARCH ROCKEFELLER UNIVERSITY 1230 YORK AVENUE NEW YORK NY 10065 131624158 200000 0 ALZHEIMERS RESEARCH RODIN THERAPEUTICS 25 FIRST ST CAMBRIDGE MA 02141 462300388 378708 0 ALZHEIMERS RESEARCH TRANSLATIONAL GENOMICS RESEAR 445 N FIFTH ST PHOENIX AZ 85004 201469 0 ALZHEIMERS RESEARCH UNIV OF MASS MEDICAL SCHOOL 55 LAKE AVENUE NORTH WORCHESTER MA 01655 043167352 150000 0 ALZHIEMERS RESEARCH UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEMORY AND AGING CENTER -DEPT NEURO SAN FRANCISCO CA 94143 680000845 100000 0 ALZHEIMERS RESEARCH UNIVERSITY OF CHICAGO MEDICAL 924 EAST 57TH ST CHICAGO IL 60637 257942 0 ALZHEIMERS RESEARCH UNIVERSITY OF SOUTHERN CALIFO UNIVERSITY PARK CAMPUS LOS ANGELES CA 90089 338898 0 ALZHEIMERS RESEARCH VANDERBILT NEUROSCIENCE DRUG 1211 MEDICAL CENTER DRIVE NASHVILLE TN 37232 620476822 300000 0 ALZHEIMERS RESEARCH VIRGINIA COMMONWEALTH 1200 EAST MARSHALL ST RICHMOND VA 23284 596001758 160000 0 ALZHEIMERS RESEARCH 18 4 Grantmaker's Description of How Grants are Used GRANT RECIPIENTS ARE SELECTED THROUGH A RIGOROUS PEER-REVIEW PROCESS, AS WELL AS AN INTERNAL REVIEW AND BOARD APPROVAL PROCESS. GRANTS FOR ALL INSTITUTIONS ARE CLOSELY MONITORED. GRANTEES MUST SUBMIT MID-YEAR AND END-OF-YEAR PROGRESS AND FINANCIAL REPORTS. SUBSEQUENT PAYMENTS TO GRANT RECIPIENTS ARE CONTINGENT UPON THE RECEIPT AND SATISFACTORY REVIEW OF THESE REPORTS. PROGRESS OF GRANT RECIPIENTS IS COMMUNICATED TO THE BOARD OF GOVENORS PERIODICALLY. SOME OF THE GRANTS LISTED IN PART II OF THIS SCHEDULE I ARE GRANTS WITH A "PARTICIPATING INTEREST," WHICH ENTITLE THE FOUNDATION TO RECEIVE, IN THE EVENT THAT THE FUNDED PROJECT IS LICENSED OR OTHERWISE COMMERCIALIZED, A PERCENTAGE OF THE LICENSING OR OTHER REVENUE THAT THE GRANTEE ORGANIZATION RECEIVES OR EQUITY IN THE RESULTING BUSINESS ENTITY. false false false false false false false false false false HOWARD FILLIT MD EXEC DIR/GOV 466752 108667 163363 738782 X 7 7901915 FAIR MKT VALUE false false false Form 990, Part VI, Line 2: Description of Business or Family Relationship of Officers, Directors, Et THE FOLLOWING FAMILY AND/OR BUSINESS RELATIONSHIPS EXIST AMONG GOVERNORS AND OFFICERS OF THE FOUNDATION: (i) LEONARD A.LAUDER AND RONALD S.LAUDER: FAMILY AND BUSINESS RELATIONSHIP; (ii) LEONARD A.LAUDER, KEVIN DIETERICH AND LISA SOMAR: BUSINESS RELATIONSHIP;(iii) LEONARD A.LAUDER, RONALD S.LAUDER AND DR. HOWARD FILLIT: BUSINESS RELATIONSHIP;(iv) ALICE SHURE AND BONNIE PFEIFER EVANS: FAMILY RELATIONSHIP;(v) MELVIN R.GOODES and NANCY GOODES: Family Relationship;(vi) LEONARD A. LAUDER AND LADY LYNN DE ROTHCHILD: BUSINESS RELATIONSHIP. Form 990, Part VI, Line 4: Description of Significant Changes to Organizational Documents During the 2015 tax year, the Foundations By-Laws were amended (a) to create "honorary governor" non-voting positions on the Foundation's board and (b) to lower the threshold for a quorum at meetings of committees of the Foundation's board from a majority of the members of the committee then in office to one-third of members of the committees then in office. Form 990, Part VI, Line 6: Explanation of Classes of Members or Shareholder THE FOUNDATION'S MEMBERS ARE THE SAME INDIVIDUALS WHO SERVE FROM TIME TO TIME AS THE FOUNDATION'S GOVERNORS. Form 990, Part VI, Line 7a: How Members or Shareholders Elect Governing Body THE FOUNDATION HAS MEMBERS WHO HAVE THE RIGHT TO ELECT AND REMOVE (WITH CAUSE) THE FOUNDATION'S GOVERNORS AND, UNDER APPLICABLE STATE LAWS, APPROVE FUNDAMENTAL CORPORATE CHANGES, SUCH AS A MERGER OR DISSOLUTION OF THE FOUNDATION. Form 990, Part VI, Line 11b: Form 990 Review Process A draft of the completed Form 990 is reviewed by the Foundation's Executive Director and by outside consultants, including legal counsel. The approved final Form 990 is signed by either the Foundation's Executive Director or Treasurer and then a copy is provided to the Board of Governors and the Foundation's officers prior to its filing with the Internal Revenue Service. Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of Conflicts AT LEAST ANNUALLY, CONFLICT OF INTEREST DISCLOURE STATEMENTS ARE CIRCULATED TO THE BOARD OF GOVERNORS AND OFFICERS FOR REVIEW AND COMPLETION. THE COMPLETED STATEMENTS ARE THEN REVIEWED UNDER THE SUPERVISION OF A FOUNDATION OFFICER. Form 990, Part VI, Line 19: Other Organization Documents Publicly Available ONLY UPON REQUEST Other Changes In Net Assets Or Fund Balances - Other Decreases FOREIGN EXCHANGE CANADA CLOSING = -$106858 Other Changes In Net Assets Or Fund Balances - Other Decreases FOREIGN EXCHANGE CURRENT YEAR = -$38980 INSTITUTE FOR THE STUDY OF AGING INC 57 WEST 57TH STREET NEW YORK NY 10019 201082179 GRANTS TO SUPPORT RESEARCH FOR COGNITIVE NY 501(C)(3) PRIVATE FOUNDATION N/A false INSTITUTE FOR THE STUDY OF AGING 57 WEST 57TH STREET NEW YORK NY 10019 201082179 DECLINE & ALZHEIMER IN KIND CONTRIBUTION NY 501 (C) (3) PRIVATE FOUNDATION N/A false INSTITUTE FOR THE STUDY OF AGING 57 WEST 57TH STREET NEW YORK NY 10019 201082179 FOR SALARIES, BENEFITS AND OTHER EXPENSE NY 501 (C) (3) PRIVATE FOUNDATION N/A false ALZHEIMERS DRUG DISCOVERY FOUNDATION OF CANADA 100 KING ST., TORONTO ONTARIO CA M5X 1G5 DRUGS TO PREVENT, CURE, ALZHEIMER'S CA N/A CANADIAN NON PROFIT N/A false false false false false false false false false false false false false true true true false false false false INSTITUTE FOR THE STUDY OF AGING INC m 830386 ACTUAL EXPENSE INSTITUTE FOR THE STUDY OF AGING INC n 660973 ACTUAL EXPENSE INSTITUTE FOR THE STUDY OF AGING INC o 2008914 ACTUAL EXPENSE